retatrutide side effects trial results of once-weekly subcutaneous on weight and metabolic markers: A systematic review and meta-analysis of randomized controlled trials The experimental GLP-1 drug 'reta'

Key takeaways Three receptors, one injection: Retatrutide targets GLP-1 (less hunger), GIP (metabolic and satiety synergy) and glucagon (slightly more energy burn)

Wegovy doses reach up to 7.2 mg, although 2.4 mg is the usual maintenance dose, and unlike Ozempic, it is licensed for weight loss in the UK

slowing titration improved tolerability

In Mar26, AstraZeneca secured the EC approval of Imfinzi as a perioperative therapy for G/GEJ cancers Total Revenue: $60.34B Founded Year: 1896 Total Employees: 1,12,800 Headquarters: Basel, Switzerland Market Cap: $328.89B Stock Exchange: SWX Roche is a global healthcare leader spanning pharmaceuticals and diagnostics, with a strong focus on oncology, immunology, neuroscience, and ophthalmology, combining innovative drugs with advanced diagnostics to drive precision medicine

The abdomen offers easy access, good visibility, and consistent absorption rates